Home

Glaxosmithkline Pharmaceuticals Ltd 52 Week Low

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

YEARLOW

₹ 1846.25

Last updated on: Apr 17, 2025

Key Highlights

  • The 52 Week Low of Glaxosmithkline Pharmaceuticals Ltd is ₹ 1846 as of 17 Apr 25 .

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 20252909.25
16 Apr 20252928.6
15 Apr 20252876.65
11 Apr 20252747.05
09 Apr 20252675.05
08 Apr 20252728.95
07 Apr 20252577.15
04 Apr 20252735.75
03 Apr 20252857.9
02 Apr 20252776.6

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting

Read more

29 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Glaxosmithkline Pharmaceuticals Ltd

Why is it important to track the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Glaxosmithkline Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Glaxosmithkline Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Glaxosmithkline Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Glaxosmithkline Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Glaxosmithkline Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Glaxosmithkline Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Glaxosmithkline Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Glaxosmithkline Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Glaxosmithkline Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions